Stage Ta/b (>  cm) and grade  or  AND
Clinical stages Ta-Ta N M (AJCC Criteria th Ed.). Staging must be done by treating investigator.
Organ confined clinical TC or clinical Ta prostate cancer that is visualized on MR imaging
Clinical stage TIC or Ta
Clinical or pathologic stage T T disease including Ta and b if feasible to treat with radiation therapy
Clinical stages Ta-Tb
Curatively treated incidental prostate cancer (T/Ta)
Prostate cancer clinical stage Ta and below
Have, at entry, confirmed by a pathology report: Carcinoma in situ (CIS) only; Ta/T high-grade disease with concomitant CIS; or Ta/T high-grade disease without concomitant CIS
Clinically localized disease (?Ta) and
Incidental histologic finding of prostate cancer (Ta or Tb using the TNM [tumor, nodes, metastasis] clinical staging system) or prostate cancer that is curative
Incidental histologic finding of prostate cancer (Ta or Tb using the tumor, nodes, metastasis [Tumor, node, metastases (TNM)] clinical staging system).
Incidental histological finding of prostate cancer (TNM stage of Ta or Tb)
Stage IIIC colorectal cancer (Ta, Na, M) or (T-a, Nb, M), or (Tb, N- N, M) (per AJCC th ed).
Patients have either Cis or Cis with Ta and/or T disease at enrollment or in the past. For those patients with only Ta or T disease at enrollment AND with no history of Cis, they must have
Clinical stages Tb  Ta
Subjects with evidence of extraprostatic extension (Ta) or seminal vesicle involvement (Tb) on clinical evaluation
Patients who are diagnosed with clinical stage Ta -Tc prostate cancer
Incidental histologic finding of prostate cancer (TNM stage of Ta or Tb)
Clinical stage T-/N-/M at presentation (patients with Ta/bN tumors will not be eligible)
Clinical stage T-Ta N/X M disease
Ta-d, N-N
Incidental histologic finding of prostate cancer (TNM stage of Ta or Tb)
Incidental histologic finding of prostate cancer (TNM stage of Ta or Tb)
Ta and Ta squamous cell carcinoma of the glottic larynx (tumor limited to one vocal cord with normal cord mobility)
Clinical stage T-Ta, N/x, M disease
Known Abl-kinase TI or TA mutation
Incidental histologic finding of prostate cancer (TNM stage of Ta or Tb).
Have newly diagnosed or recurrent multi-focal Ta, large Ta, high grade Ta, carcinoma in situ (CIS) or T bladder cancer
Incidental histological finding of prostate cancer (TNM stage of Ta or Tb)
Patients must have a biopsy proven newly diagnosed locally confined, stage Ta, Ta or Tb prostate cancer
Have histologically confirmed organ-confined prostate cancer - Clinical Stage T or Ta,
Have non-metastatic prostate cancer and =< clinical Ta disease at diagnosis
Have received a diagnosis of localized disease confined to the prostate, with no regional lymph node or distant metastasis (stages T, Ta, Tb, T, Ta, Tb)
Received a diagnosis of localized disease confined to the prostate, with no regional lymph node or distant metastasis (stages T, Ta, Tb, T, Ta, Tb)
Participants are eligible if they received a diagnosis of localized disease confined to the prostate, with no regional lymph node or distant metastasis (stages T, Ta, Tb, T, Ta, Tb)
Received a diagnosis of localized disease confined to the prostate, with no regional lymph node or distant metastasis (stages T, Ta, Tb, T, Ta, Tb, Tc, T, Ta, Tb, Tc)
Clinical stage =< Ta by digital rectal exam (DRE)
Incidental histologic finding of prostate cancer (Ta or Tb using the tumor, nodes, metastasis [TNM] clinical staging system)
Patient with intermediate risk, early-stage organ-confined prostate cancer (Ta up to Tb, N, M) and voluntarily chooses ExAblate thermal ablation as the non-invasive treatment, who may currently be on watchful waiting or active surveillance and not in need of imminent radical therapy.
Incidental histologic finding of prostate cancer (Ta or Tb using the TNM [tumor, nodes, metastasis] clinical staging system) or prostate cancer that is curative.
Clinical stage: =< Ta & N or NX & M or MX
Clinical stage T-Ta, N, M urothelial bladder cancer